Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin to Prevent Delayed Chemotherapy-induced Nausea and Vomiting
NCT04918069Phase 2Completed
- Sponsor
- Christian Medical College, Vellore
- Start
- Oct 2019
- Primary completion
- May 2022
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Capsaicin with Placebo (2 arms). Primary endpoints: Nausea at 15 days and Vomiting at 15 days. Started Oct 2019; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04918069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04918069.